Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477906
Status:
UNKNOWN
Last Update Posted:
2015-12-03
First Post:
2007-05-22
Brief Title:
M-Vax Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Sponsor:
AVAX Technologies
Organization:
AVAX Technologies